Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages.
AUTOR(ES)
Whitnack, E
RESUMO
The antiphagocytic properties of the streptococcal hyaluronic acid capsule were explored in a system in which binding of the organism to the phagocyte, but not ingestion, could occur. The capsule was found to be highly effective in preventing attachment of two strains of group A streptococci to mouse peritoneal macrophages. Variation in attachment with phase of growth in broth culture (low in early log phase, high in late-log phase and thereafter) could be accounted for by production and subsequent loss of capsule. Hyaluronidase treatment removed the capsule and increased adherence; treatment with proteolytic enzymes removed M protein and decreased resistance to phagocytosis in whole human blood but did not remove the capsule or increase adherence to the mouse peritoneal macrophages.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=351415Documentos Relacionados
- Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.
- Interaction of Chlamydia psittaci with mouse peritoneal macrophages.
- Immediate cytotoxicity of Chlamydia trachomatis for mouse peritoneal macrophages.
- Plasma membrane polypeptides of resident and activated mouse peritoneal macrophages.
- Early interactions of herpes simplex virus with mouse peritoneal macrophages.
